Lentiviral overexpression of GRK6 alleviates L-dopainduced dyskinesia in experimental Parkinson's disease, Sci Transl Med, vol.2, pp.28-28, 2010. ,
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia, Ann Neurol, vol.57, pp.17-26, 2005. ,
D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus, J Physiol, vol.586, pp.2121-2142, 2008. ,
Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: functional consequences, Eur J Neurosci, vol.12, pp.2985-2992, 2000. ,
Pharmacological analysis demonstrates dramatic alteration of D1 Dopamine receptor neuronal distribution in the rat analog of L-DOPAinduced dyskinesia, J Neurosci, vol.29, pp.4829-4835, 2009. ,
Pathophysiology of levodopainduced dyskinesia: potential for new therapies, Nat Rev Neurosci, vol.2, pp.577-588, 2001. ,
Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J Neurosci, vol.21, pp.6853-6861, 2001. ,
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nat Med, vol.9, pp.762-767, 2003. ,
Activity-dependent dynamics and sequestration of proteasomes in dendritic spines, Nature, vol.441, pp.1144-1148, 2006. ,
Continuous and intermittent nicotine treatment reduces L-3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesias in a rat model of Parkinson's disease, J Pharmacol Exp Ther, vol.327, pp.239-247, 2008. ,
Dopamine induces a PI3-kinase-independent activation of Akt in striatal neurons: a new route to cAMP response element-binding protein phosphorylation, J Neurosci, vol.22, pp.8911-8921, 2002. ,
URL : https://hal.archives-ouvertes.fr/hal-02197517
Ratings of L-DOPA-induced dyskinesia in the unilateral 6-OHDA lesion model of Parkinson's disease in rats and mice, Curr Protoc Neurosci Chapter, issue.9, p.25, 2007. ,
L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin-and glutamic acid decarboxylase mRNA, Eur J Neurosci, vol.10, pp.2694-2706, 1998. ,
N-methyl-Daspartate receptor-and metabotropic glutamate receptor-dependent long-term depression are differentially regulated by the ubiquitinproteasome system, Eur J Neurosci, vol.30, pp.1443-1450, 2009. ,
Modification of Parkinsonismchronic treatment with L-dopa, N Engl J Med, vol.280, pp.337-345, 1969. ,
Comparative selectivity and specificity of the proteasome inhibitors BzLLLCOCHO, PS-341, and MG-132, Cancer Res, vol.66, pp.6379-6386, 2006. ,
Ubiquitin-dependent regulation of the synapse, Annu Rev Neurosci, vol.27, pp.223-246, 2004. ,
Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice, Proc Natl Acad Sci U S A, vol.97, pp.1879-1884, 2000. ,
Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc Natl Acad Sci U S A, vol.107, pp.21824-21829, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01055134
Dopamine transporter binding is unaffected by L-DOPA administration in normal and MPTP-treated monkeys, Plos One, vol.5, p.14053, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-01055105
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization, Mol Pharmacol, vol.74, pp.59-69, 2008. ,
Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain, J Neurosci Methods, vol.163, pp.76-82, 2007. ,
Dual effect of high-frequency stimulation on subthalamic neuron activity, J Neurosci, vol.23, pp.8743-8751, 2003. ,
Proteasome inhibitors: recent advances and new perspectives in medicinal chemistry, Curr Top Med Chem, vol.10, pp.232-256, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00807658
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter, Nature, vol.379, pp.606-612, 1996. ,
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanineinduced dyskinesia in experimental Parkinson's disease, J Neurosci, vol.27, pp.14338-14348, 2007. ,
Parkindeficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons, J Biol Chem, vol.278, pp.43628-43635, 2003. ,
, Pathogenesis of levodopainduced dyskinesia: focus on D1 and D3 dopamine receptors, pp.25-29, 2005.
Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanineinduced dyskinesia, J Neurosci, vol.25, pp.2102-2107, 2005. ,
Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic nonhuman primates, Neurobiol Dis, vol.26, pp.452-463, 2007. ,
Glutamate stimulates glutamate receptor interacting protein 1 degradation by ubiquitin-proteasome system to regulate surface expression of GluR2, Neuroscience, vol.145, pp.100-109, 2007. ,
Alterations of striatal NMDA receptor subunits associated with the development of dyskinesia in the MPTPlesioned primate model of Parkinson's disease, Neuropharmacology, vol.48, pp.503-516, 2005. ,
Molecular mechanisms of L-DOPA-induced dyskinesia, Nat Rev Neurosci, vol.9, pp.665-677, 2008. ,
A role for the ubiquitin-proteasome system in activity-dependent presynaptic silencing, J Neurosci, vol.30, pp.1798-1809, 2010. ,
Profound neuronal plasticity in response to inactivation of the dopamine transporter, Proc Natl Acad Sci U S A, vol.95, pp.4029-4034, 1998. ,
Nicotine coregulates multiple pathways involved in protein modification/degradation in rat brain, Brain Res Mol Brain Res, vol.132, pp.181-191, 2004. ,
Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates, Methods Enzymol, vol.398, pp.364-378, 2005. ,
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism, Nature, vol.392, pp.605-608, 1998. ,
Dopamine decreases striatal enkephalin turnover and proenkephalin messenger RNA abundance via D2 receptor activation in primary striatal cell cultures, Neuroscience, vol.53, pp.665-672, 1993. ,
Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor, Cell, vol.111, pp.219-230, 2002. ,
Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal, J Biol Chem, vol.279, pp.35671-35678, 2004. ,
A transgenic mouse model of the ubiquitin/proteasome system, Nat Biotechnol, vol.21, pp.897-902, 2003. ,
Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease, Eur J Neurosci, vol.15, pp.120-132, 2002. ,
Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia, Exp Neurol, vol.194, pp.66-75, 2005. ,
Agonist stimulation provokes dendritic and axonal dopamine D(1) receptor redistribution in primary cultures of striatal neurons, Neuroscience, vol.99, pp.257-266, 2000. ,
Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons, Synapse, vol.60, pp.194-204, 2006. ,
Increased slow oscillatory activity in substantia nigra pars reticulata triggers abnormal involuntary movements in the 6-OHDA-lesioned rat in the presence of excessive extracellular striatal dopamine, Neurobiol Dis, vol.22, pp.586-598, 2006. ,
Control of chronic pain by the ubiquitin proteasome system in the spinal cord, J Neurosci, vol.27, pp.8226-8237, 2007. ,
Ubiquitin-mediated proteasome activity is required for agonist-induced endocytosis of GluRs, Curr Biol, vol.13, pp.2073-2081, 2003. ,
Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age, J Biol Chem, vol.278, pp.48120-48128, 2003. ,
Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys, Ann Neurol, vol.62, pp.588-596, 2007. ,
Multiple myeloma, Lancet, vol.374, pp.324-339, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00130206
Distinct changes in cAMP and extracellular signal-regulated protein kinase signalling in L-DOPA-induced dyskinesia, Plos ONE, vol.5, p.12322, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00628011
The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor lovastatin reduces severity of L-DOPA-induced abnormal involuntary movements in experimental Parkinson's disease, J Neurosci, vol.28, pp.4311-4316, 2008. ,
Antagonizing L-type Ca 2? channel reduces development of abnormal involuntary movement in the rat model of L-3,4-dihydroxyphenylalanine-induced dyskinesia, Biol Psychiatry, vol.65, pp.518-526, 2009. ,
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase, Nat Genet, vol.25, pp.302-305, 2000. ,
Synaptic recruitment of AMPA glutamate receptor subunits in levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate, Synapse, vol.64, pp.177-180, 2010. ,
Nucleus accumbens neurons exhibit synaptic scaling that is occluded by repeated dopamine pre-exposure, Eur J Neurosci, vol.30, pp.539-550, 2009. ,
Psychomotor stimulants and neuronal plasticity, Neuropharmacology, vol.47, pp.61-79, 2004. ,